Market Analysis - Addiction Summit 2018
Addiction is an essential, chronic disease of brain reward, inspiration, memory and related circuitry. Brokenness in these circuits prompts to characteristic biological, mental, social and profound appearances. This is reflected in an individual pathologically seeking after reward and additionally, alleviation by substance utilize and different practices.
Addiction Science gives a gathering to important research and viewpoints that add to enhancing the nature of look after individuals with unfortunate liquor, tobacco, or other medications utilize and addictive practices over a range. Points of intrigue deliver issues identified with the accompanying: the range of unfortunate utilization of liquor, tobacco, and different medications among the scope of influenced people the variety of clinical anticipation and treatment practices and recognizable proof and administration of medicinal, psychiatric, social, and other well-being results of substance utilize.
As indicated by Australian scientists the first since forever give an account of overall enslavement insights. They found around 240 million individuals around the globe are reliant on liquor, more than a billion people smoke, and around 15 million individuals utilize infusion medications, for example, heroin.
The report utilizes information from sources including the World Health Organization and the United Nations Office on Drugs and Crime, as indicated by NPR. The analysts say the report is critical in light of the fact that it gives a gauge of medication and liquor utilize around the world, alongside examinations among various locales.
As indicated by the report, individuals in Eastern Europe smoke and drink more than any other person on the planet, while Asians drink the minimum. "One thing that emerges is nations that are overwhelmingly Muslim have a much lower rate of liquor utilization. Liquor utilization is likewise lower at all created nations, the report found.
In the UK, figures for medication clients exhibiting for treatment identified with tricky medication abuse are drawn specifically from the National Drug Treatment Monitoring System (NDTMS). The NDTMS identifies with the way toward gathering, grouping and examining data from and for those included in the medication treatment segment. The NDTMS is an advancement of the local medication abuse databases (RDMDs), which have been set up since the late 1980s.
The most recent measurements from the NDTMS demonstrate that in 2011-12 there were 197,110 people matured 18 and over who were in treatment, with 69,434 of those having begun new treatment travels in that year. Of the 63,020 that left treatment that year, 29,855 (45%) left in the wake of having finished their treatment and beat their reliance on the medication for which treatment was looked for.
Singapore is the heart of Southeast Asia. Though physically small, Singapore is an economic giant. It has been Southeast Asia's most modern city for over a century. The city blends Malay, Chinese, Arab, Indian and English cultures and religions. Its unique ethnic tapestry affords visitors a wide array of sightseeing and culinary opportunities from which to choose. A full calendar of traditional festivals and holidays celebrated throughout the year adds to its cultural appeal. In addition, Singapore offers luxury hotels, delectable cuisine and great shopping. It is one of the major Addiction hubs in Malaysia. There are about 500 retreat centers in Singapore. Prestigious universities of the country are working in the field of Addiction Therapy. It features Best Addiction research centers, Rehabilitation Centres & Counseling Centres; many addictions related Associations and Societies. Top universities of Malaysia are into addiction research.
Why to attend??
With members from around the world focused on learning about Alcoholism and Drug Addiction Disease, Treatment and Recovery. The conference brings together some of the latest, most thought-provoking research from around the world. In a small and intimate setting, researchers and clinicians from all corners of the world are able to exchange ideas, share findings and discuss future collaborations. This will produce a broader international knowledge-base and wonderful advances in the field of Addictive Disorders and Alcoholism. World-renowned speakers, the most recent techniques, and the newest updates in Alcoholism and Addictive Disorders are hallmarks of this Conference.
Benefits of attending
- One on One Meeting with Eminent Speakers
- Keynote sessions by world’s most eminent researchers
- Thought to provoke Symposiums and Workshops
- Preconference workshops in all major countries
- Earn up to 12 CME Credits** by participating in the conference
- CPD Credits by CPD Standards Office, UK
- IOCM Certification
- Laudable talks by the top-notch of the global scientific community
- Published your abstracts in the respective supporting International Journals
- Each abstract will receive a (DOI) Number provided by Cross Ref
- Remarkable Awards and Global Recognition to meritorious Researchers
- Nominations for Best Poster Award
- Outstanding Young Researcher Award geared towards best budding young research.
A Unique Opportunity for Advertisers and Sponsors at this International event
Major Addiction Associations and Societies around the Globe
Top Universities in Singapore:
Addiction Treatment, Addiction Treatment Counselors, Case Workers, CEO’s, Managers And Leaders Of Addiction Treatment Centres, Clinical Nurses, Clinical Directors, Counselors, Doctors, Nurses, Occupational Therapists, Psychiatrists, Psychologists, Counselors, Licensed Social Workers, Licensed Alcohol And Drug Counselors, Physicians, Case Management, Geriatrics / Gerontology, Marriage & Family Therapy, Medicine, Military Specialties, Nursing, Pain Management, Paramedicine, Pharmacy, Primary Care / Family Practice, Researchers And Academics, Counselors And Students And Other Health Care Professionals
- Industry 21%
- Student 17%
- Academia 42%
- Government 11%
- Others 9%
Projection: Growth by next 5-10 years
AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Pfizer, Johnson & Johnson, and GlaxoSmithKline. Eli Lilly: Zyprexa drug has the largest market share of the market, at 26% ($4.70 billion). AstraZeneca: Seroquel, at 2nd place ($4.45 billion) remains the most widely prescribed antipsychotic. Bristol-Myers Squibb: Abilify saw a 30% growth in sales from 2007 to 2008 to $2.15 billion. Zyprexa earned revenues of $4.70 billion in 2008, representing 23% of Eli Lilly's total earnings in that year. Total sales for Zyprexa decreased 1% from 2007 to 2008, due to decreased demand from increased generic competition. Zyprexa was approved in 2000 to treat schizophrenia. Eli Lilly's patent for Zyprexa expires on April 23, 2011. Abilify earned revenues of $2.15 billion in 2008 for a growth of 30% from 2007 to 2008. Abilify was approved in 2007 as an adjunctive treatment for major depressive disorder as well as a therapeutic for schizophrenia and bipolar disorder in adolescents. J&J's antipsychotics franchise, including the Risperdal formulations and Invega, earned revenues of $3.8 billion in 2008; a decrease of 24% from 2007 to 2008. Invega was approved in 2007 by the FDA to treat schizophrenia.
Major drugs Companies:
- Universal Health Services Inc.
- Johnson & Johnson
- Eli Lilly
- Bristol-Meyer Squibb
- AstellasPharma Inc. and more
Addiction Summit 2018 welcomes all attendees, presenters, and exhibitors from all over the world to Singapore. We are delighted to invite you all to attend and register for the 8th International Conference on Addictive Disorders and Alcoholism scheduled during May 17-18, 2018 at Singapore. The organizing committee is gearing up for an exciting and informative conference program including Keynote presentation, plenary lectures, symposia, workshops and poster presentations on various topics related to Addictive Disorders and Alcoholism around the theme: Accelerating the Rehabilitation, Treatment and Therapies in Addiction.
Addictive Disorders and Alcoholism is a two-day event provides a perfect platform for leading scientists, researchers, decision-makers and other players to gain the latest information on topics of current research like Addiction, Alcoholism, Marijuana and Opioid Addiction, Depression & Anxiety Disorders, Eating Disorders, Addiction Treatment and Rehabilitation, etc.